Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |